PMID: 423042Mar 1, 1979

The effect of cimetidine on maldigestion in cystic fibrosis

The Journal of Pediatrics
K L CoxR R Dooley


Ten patients (6 to 27 years of age) who had severe pancreatic exocrine insufficiency due to cystic fibrosis were studied to determine whether cimetidine would improve dietary fat and nitrogen absorption. When a constant diet was consumed and oral pancreatic enzymes were administered, the addition of cimetidine (150 or 200 mg taken orally one-half hour before meals) signficantly reduced fecal fat excretion from 25.3 +/- 2.9 to 17.3 +/- 2.1 gm/24 hours and fecal nitrogen excretion from 4.5 +/- 0.6 to 3.4 +/- 0.5 gm/24 hours (P less than 0.05). Lower doses of cimetidine resulted in less significant reductions of steatorrhea and azotorrhea. Cimetidine may be a useful adjunct to oral pancreatic enzyme therapy in patients with cystic fibrosis who continue to have steatorrhea and azotorrhea with enzyme therapy alone.


Feb 1, 1978·The Journal of Pediatrics·I AntonowiczH Shwachman
Feb 1, 1976·The Journal of Pediatrics·C L MorinA Bonin
Aug 1, 1967·Gut·H S Wiggins


May 1, 1985·European Journal of Pediatrics·A SomogyiR Gugler
Jan 1, 1988·European Journal of Clinical Pharmacology·J PrandotaJ T Wilson
May 1, 1987·Digestive Diseases and Sciences·C A YoungbergJ B Dressman
Jun 1, 1982·Digestive Diseases and Sciences·E P DiMagno
Jun 1, 1982·Digestive Diseases and Sciences·D Y Graham
Oct 1, 1987·Digestive Diseases and Sciences·R D HoffmanG K Powell
Jan 1, 1991·Nutrition Research Reviews·R ShepherdT L Holt
Sep 1, 1981·Australian Paediatric Journal·E A Mitchell, R B Elliott
May 18, 1999·Archives of Disease in Childhood·C J TaylorN Read
Oct 18, 1986·British Medical Journal·C B Lamers, J B Jansen
Nov 1, 1987·Gut·P L Zentler-Munro
Nov 24, 1998·Journal of Clinical Pharmacology·W A MaishG L Kearns
Jan 1, 1981·Acta paediatrica Scandinavica·F de BiévilleK F Kerrebijn
Jan 1, 1985·Acta paediatrica Scandinavica·D M ChalmersM S Losowsky
Jan 1, 1985·Acta Paediatrica Scandinavica. Supplement·M SinaasappelH J Neijens
Oct 18, 1986·British Medical Journal·N H Kitching
Nov 17, 2005·Pediatric Pulmonology·James M LittlewoodSteven P Conway
Aug 11, 2000·Paediatric Drugs·J M Littlewood, S P Wolfe
Dec 1, 1987·Alimentary Pharmacology & Therapeutics·P L Zentler-Munro, T C Northfield
Feb 1, 1983·Drug Intelligence & Clinical Pharmacy·E M Sorkin, D L Darvey
Aug 1, 1981·British Journal of Clinical Pharmacology·R BradbearR K Roberts
Aug 26, 1998·Journal of the Royal Society of Medicine·P DurieL Ellis
Jan 1, 1982·Scandinavian Journal of Gastroenterology·I L SalomA Doscherholmen

Related Concepts

Celiac Disease
Pulmonary Cystic Fibrosis
Malabsorption Syndrome
Pancreatic Extracts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Computational Methods for Protein Structures

Computational methods employing machine learning algorithms are powerful tools that can be used to predict the effect of mutations on protein structure. This is important in neurodegenerative disorders, where some mutations can cause the formation of toxic protein aggregations. This feed follows the latests insights into the relationships between mutation and protein structure leading to better understanding of disease.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.